| Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis D Karussis, C Karageorgiou, A Vaknin-Dembinsky, B Gowda-Kurkalli, ... Archives of neurology 67 (10), 1187-1194, 2010 | 1157 | 2010 |
| Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ... The Lancet 391 (10127), 1263-1273, 2018 | 1075 | 2018 |
| The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review D Karussis Journal of autoimmunity 48, 134-142, 2014 | 467 | 2014 |
| Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis I Kassis, N Grigoriadis, B Gowda-Kurkalli, R Mizrachi-Kol, T Ben-Hur, ... Archives of neurology 65 (6), 753-761, 2008 | 438 | 2008 |
| Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open … R Kapoor, PR Ho, N Campbell, I Chang, A Deykin, F Forrestal, N Lucas, ... The Lancet Neurology 17 (5), 405-415, 2018 | 370 | 2018 |
| Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis: results of phase 1/2 and 2a … P Petrou, Y Gothelf, Z Argov, M Gotkine, YS Levy, I Kassis, ... JAMA neurology 73 (3), 337-344, 2016 | 344 | 2016 |
| Transplanted multipotential neural precursor cells migrate into the inflamed white matter in response to experimental autoimmune encephalomyelitis T Ben‐Hur, O Einstein, R Mizrachi‐Kol, O Ben‐Menachem, E Reinhartz, ... Glia 41 (1), 73-80, 2003 | 325 | 2003 |
| The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group MS Freedman, A Bar-Or, HL Atkins, D Karussis, F Frassoni, H Lazarus, ... Multiple Sclerosis Journal 16 (4), 503-510, 2010 | 291 | 2010 |
| Intraventricular transplantation of neural precursor cell spheres attenuates acute experimental allergic encephalomyelitis O Einstein, D Karussis, N Grigoriadis, R Mizrachi-Kol, E Reinhartz, ... Molecular and Cellular Neuroscience 24 (4), 1074-1082, 2003 | 265 | 2003 |
| Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative … D Karussis, I Kassis, BGS Kurkalli, S Slavin Journal of the neurological sciences 265 (1-2), 131-135, 2008 | 262 | 2008 |
| The spectrum of post-vaccination inflammatory CNS demyelinating syndromes D Karussis, P Petrou Autoimmunity reviews 13 (3), 215-224, 2014 | 240 | 2014 |
| Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein H Rosenmann, N Grigoriadis, D Karussis, M Boimel, O Touloumi, ... Archives of Neurology 63 (10), 1459-1467, 2006 | 235 | 2006 |
| Transplanted neural precursor cells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis O Einstein, N Grigoriadis, R Mizrachi-Kol, E Reinhartz, E Polyzoidou, ... Experimental neurology 198 (2), 275-284, 2006 | 211 | 2006 |
| APOE genotype is a major predictor of long-term progression of disability in MS J Chapman, S Vinokurov, A Achiron, DM Karussis, K Mitosek–Szewczyk, ... Neurology 56 (3), 312-316, 2001 | 209 | 2001 |
| Cell-based therapeutic strategies for multiple sclerosis NJ Scolding, M Pasquini, SC Reingold, JA Cohen Brain 140 (11), 2776-2796, 2017 | 198 | 2017 |
| Diagnosis and classification of optic neuritis A Petzold, CL Fraser, M Abegg, R Alroughani, D Alshowaeir, R Alvarenga, ... The Lancet Neurology 21 (12), 1120-1134, 2022 | 182 | 2022 |
| Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis P Petrou, I Kassis, N Levin, F Paul, Y Backner, T Benoliel, FC Oertel, ... Brain 143 (12), 3574-3588, 2020 | 180 | 2020 |
| A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity? D Karussis, RR Leker, A Ashekenazi, O Abramsky Annals of Neurology: Official Journal of the American Neurological …, 1998 | 163 | 1998 |
| The 11-year long-term follow-up study from the randomized BENEFIT CIS trial L Kappos, G Edan, MS Freedman, X Montalban, HP Hartung, B Hemmer, ... Neurology 87 (10), 978-987, 2016 | 151 | 2016 |
| Bone marrow mesenchymal stem cells: agents of immunomodulation and neuroprotection I Kassis, A Vaknin-Dembinsky, D Karussis Current stem cell research & therapy 6 (1), 63-68, 2011 | 148 | 2011 |
